Validating the Children's Depression Inventory in the context of Rwanda

BMC Pediatr. 2016 Feb 22:16:29. doi: 10.1186/s12887-016-0565-2.

Abstract

Background: Depression is often co-morbid with chronic conditions, and when combined with HIV it can increase progression and reduce survival. A brief and accurate screening tool for depression among children living with HIV is necessary to increase access to mental health care and improve HIV-related outcomes in the long-term.

Methods: A validation study was conducted, comparing the Children's Depression Inventory (CDI) with a structured clinical assessment as the gold standard among children living with HIV ages 7-14 years in Rwanda. The response rate was 87 % and the analysis was performed among 100 study participants.

Results: Twenty-five percent of children had a diagnosis of depression based on the clinical interview. Sensitivity of the CDI ranged from 44 to 76 % and specificity was 92 to 100 % for cut-off scores from 5 to 9. The area under the curve (AUC) for receiver operating characteristic analysis, an estimate of overall accuracy, was 0.87 (95 % confidence interval: 0.77 - 0.97).

Conclusions: The significant prevalence of depression among children living with HIV in Rwanda reflects a critical need to advance mental health care in this population. Although overall accuracy of the CDI is reasonable in this context, further research needs to be done to develop a more sensitive measure of depression in this vulnerable population. Development of a highly sensitive screening measure will be a fundamental step towards improving access to mental health care among children living with HIV, potentially improving health outcomes and quality of life in the long-term as this vulnerable population transitions into adulthood.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adolescent
  • Anti-HIV Agents / therapeutic use
  • Child
  • Chronic Disease
  • Depression / diagnosis*
  • Depression / epidemiology
  • Depression / etiology
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / psychology*
  • Humans
  • Male
  • Psychiatric Status Rating Scales*
  • Rwanda
  • Sensitivity and Specificity

Substances

  • Anti-HIV Agents